| Net Cash Provided by (Used in) Operating Activities |
$104,543 |
USD |
-46% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$217,906 |
USD |
-50% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$4,500 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
15,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
8,466,953 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$108,863 |
USD |
-331% |
Q1 2025 |
Q1 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Operating Lease, Liability |
$346,817 |
USD |
-16% |
Q1 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$421,436 |
USD |
-21% |
Q1 2025 |
Q3 2025 |
| Operating Lease, Liability, Current |
$53,222 |
USD |
16% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$80,837 |
USD |
4% |
Q1 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$23,687 |
USD |
-57% |
Q1 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
$33,359 |
USD |
-1781% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$74,619 |
USD |
-38% |
Q1 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
$84,024 |
USD |
3.9% |
Q1 2025 |
Q3 2025 |
| Current Income Tax Expense (Benefit) |
$252,359 |
USD |
20% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
4,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Four |
$96,163 |
USD |
14% |
Q1 2025 |
Q3 2025 |
| Additional Paid in Capital |
$987,034 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$980 |
USD |
0% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$270,053 |
USD |
51% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |